• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDSHAPE, INC. ACTIVE ADAPTIVE; DYNANAIL, 10 X 220MM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDSHAPE, INC. ACTIVE ADAPTIVE; DYNANAIL, 10 X 220MM Back to Search Results
Catalog Number 1200-01-1022
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code Unspecified Infection (1930)
Date of Event 01/05/2025
Type of Reportable Event Serious Injury
Event or Problem Description
Revision surgery - due to infection.
 
Additional Manufacturer Narrative
Additional reporting on this event will be provided as a supplemental report to this document as soon as it becomes available.
 
Additional Manufacturer Narrative
See h6 and h11.The dynanail ttc was explanted (b)(6) 2025 due to infection.The exact cause of the infection was not relayed and could have been associated with the original implant or unrelated but the location of the reported infection remains unknown.The parts were not returned for analysis.It is unknown if the surgical technique was adhered to due to limited information provided.As there was no reported deficiency with the dynanail construct, and the infection cannot be definitely attributed to dynanail, the root cause shall remain unknown.The dynanail risk analysis matrix documents were reviewed.Multiple line items/causes are associated with removal/explant of the device with varying degrees of detection, patient/device severity, and occurrence.Complaint history was reviewed from mar 1, 2024 (1st complaint records in agile) to feb 28, 2025, resulting in two complaints (including this one) of a dynanail ttc explant due to infection.Based on a sales volume of 1545 from mar 1, 2024, to feb 28, 2025, the occurrence level of remote is appropriate for removal due to infection.The dynanail risk analysis matrices were generated using the legacy medshape risk management sop, occurrence level comparison is in alignment with that procedure.The reported complaint did not indicate any evidence of product failure upon evaluation.Potential causes of revision surgery due to infection are appropriately identified in the product risk analysis matrix.Although the specific cause of the revision surgery was infection, it remains unknow the actual cause of the infection.The failure mode and cause are within the acceptable limits identified in the product risk analysis matrix and there is no indication of a systemic product issue.Therefore, a capa is not justified.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ACTIVE ADAPTIVE
Common Device Name
DYNANAIL, 10 X 220MM
Manufacturer (Section D)
MEDSHAPE, INC.
1575 northside dr. nw
suite 440
atlanta GA 30318
Manufacturer (Section G)
MEDSHAPE, INC.
1575 northside dr. nw
suite 440
atlanta GA 30318
Manufacturer Contact
stacey bonnell
1575 northside dr nw
suite 440
atlanta, GA 30318
4847879764
MDR Report Key21270245
Report Number3007593722-2025-00001
Device Sequence Number8071104
Product Code HSB
UDI-Device IdentifierM97012000110220
UDI-PublicM97012000110220
Combination Product (Y/N)N
Initial Reporter CountryUS
PMA/510(K) Number
D155711
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2024
Device Explanted Year2025
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Company Representative
Initial Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup
Report Date (Section B) 09/19/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Catalogue Number1200-01-1022
Device Lot NumberD0100N
Was Device Available for Evaluation? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 01/09/2025
Supplement Date Received by Manufacturer08/25/2025
Initial Report FDA Received Date01/29/2025
Supplement Report FDA Received Date09/19/2025
Was Device Evaluated by Manufacturer? (Y/N) No
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age68 YR
Patient SexFemale
-
-